Search clinical trials for: enamel fluoride uptake

Total 5566 results

Sunnybrook Health Sciences Centre

Withdrawn

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

Major Depression

Canada
Weill Medical College of Cornell University
Forest Laboratories

Terminated

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Depression | Multiple Sclerosis

United States
University Hospital Muenster

Unknown

Study on Amino Acid Uptake in Brain Tumors

Brain Neoplasms

Germany
Hamilton Health Sciences Corporation
Eli Lilly and Company

Completed

Olanzapine in the Treatment of Hair Pulling (Trichotillomania)

Trichotillomania

Canada
University of Minnesota
AstraZeneca; Jensen, Jonathan B., M.D.

Completed

A Comparative Study of New Medications for Psychosis in Adolescents

Psychotic Disorders | Schizophrenia | Schizoaffective Disorders | Schizophreniform Disorders

United States
Finnish Institute for Health and Welfare
Finnish Foundation for Alcohol Studies

Completed

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Depression | Alcoholism

Finland
Sheba Medical Center
H. Lundbeck A/S

Unknown

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Depressive Syndrome

Israel
Eli Lilly and Company

Completed

Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
Pfizer

Completed

Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

Pain
Abbott

Completed

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Schizophrenia

United States
University of California, San Francisco

Completed

Flushes and Sertraline Trial

Menopause-Hot Flashes

United States
Abbott

Terminated

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Bipolar Disorder

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Schizophrenia | Schizoaffective Disorder

Australia, Belgium, Brazil, Croatia, Czech Republic, Mexico, Slovakia, Spain
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Pennsylvania College of Optometry

Completed

A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children

Convergence Insufficiency

United States
University of Arizona

Completed

Bupropion Treatment for Youth Smoking Cessation

Nicotine Dependence

United States
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Schizophrenia | Extrapyramidal Syndrome

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Social Anxiety Disorder
National Institute of Environmental Health Sciences...

Completed

Ozone Exposure and Dose Delivered to Human Lungs

Lung Disease

United States
Université Catholique de Louvain
Fonds National de la Recherche Scientifique

Completed

18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone

Paget's Disease of Bone

Belgium
Herlev Hospital
University Hospital, Gentofte, Copenhagen

Unknown

Preoperative Assessment of Colon Tumor

Colorectal Cancer | Colorectal Tumor

Denmark
Utrecht Institute for Pharmaceutical Sciences

Completed

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

ADHD

Netherlands
The University of New South Wales

Completed

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

Bipolar Disorders

Australia
National Health Research Institutes, Taiwan
Chang Gung Memorial Hospital; National Science Council, Taiwan; Taipei Medical... and other collaborators

Unknown

Clinical Pharmacogenomics of Antidepressant Response

Major Depression

Taiwan
National Institute of Mental Health (NIMH)

Completed

Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Bronx VA Medical Center

Unknown

DBT and Escitalopram in Borderline Personality Disorder

Borderline Personality Disorder

United States
National Institute of Mental Health (NIMH)

Terminated

Treatment of Depression in Youth With Bipolar Disorders

Depression | Bipolar Disorder
Prestwick Pharmaceuticals

Completed

Efficacy and Safety of Tetrabenazine in Chorea

Huntington's Disease
University of Pittsburgh
Mental Health Intervention Research Center (MHIRC)

Completed

Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study

Major Depression

United States
UMC Utrecht
Utrecht University

Terminated

Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.

Chronic Neuropathic Pain

Netherlands
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline

Completed

Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease

Myocardial Infarction | Smoking | Cardiovascular Disease | Unstable Angina

United States

Search clinical trials for: enamel fluoride uptake

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations